Philip Lee Miller, MD
Endocrinology, Diabetes & Metabolism · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Miller’s office at (408) 358-8855 to ask if they take your plan before you enroll.
California Medical Board record
Licence G24699 · Current
Licensed to practise in California · since 1973 · expires 2028-07-31 · University of California, San Diego School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$18,239
Pharmacies billed $18,239 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 306) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
208 generic and 98 brand-name prescriptions · $18,239 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 12 | $9,861 | $822 |
| Estradiol (Twice Weekly) | 25 | $1,279 | $51 |
| Levoxyl | 61 | $817 | $13 |
| Progesterone | 28 | $411 | $15 |
| Rosuvastatin | 15 | $199 | $13 |
See all 9 drugs
| Ozempic | 12 | $9,861 | $822 |
| Estradiol (Twice Weekly) | 25 | $1,279 | $51 |
| Levoxyl | 61 | $817 | $13 |
| Progesterone | 28 | $411 | $15 |
| Rosuvastatin | 15 | $199 | $13 |
| Allopurinol | 17 | $49 | $3 |
| Glipizide | 25 | $25 | $1 |
| Losartan | 15 | $17 | $1 |
| Pramipexole Dihydrochloride | 11 | $8 | $1 |
Year by year
| 2024 | 306 | 35 | 0% (0) | 32% | $18,239 |
| 2023 | 209 | 27 | 0% (0) | None | $24,725 |
| 2022 | 112 | 15 | 0% (0) | None | $17,059 |
| 2021 | 108 | 16 | 0% (0) | 54% | $21,338 |
| 2020 | 122 | 16 | 0% (0) | None | $20,787 |
| 2019 | 105 | 16 | 0% (0) | None | $163,585 |
| 2018 | 143 | 20 | 0% (0) | 41% | $180,713 |
| 2017 | 237 | 29 | 0% (0) | None | $17,898 |
| 2016 | 287 | 33 | 0% (0) | None | $31,548 |
| 2015 | 223 | 31 | None | 49% | $19,693 |
| 2014 | 203 | 30 | 0% (0) | 38% | $10,811 |
| 2013 | 84 | 17 | 0% (0) | 46% | $4,980 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Vivelle-Dot | 11 | $1,929 | $175 |
| Tirosint | 11 | $1,427 | $130 |
| Levoxyl | 45 | $614 | $14 |
| Allopurinol | 14 | $206 | $15 |
| Progesterone | 13 | $193 | $15 |
| Metformin | 15 | $140 | $9 |
| Losartan | 11 | $132 | $12 |
| Glipizide | 13 | $52 | $4 |
2022: 3 drugs
| Vivelle-Dot | 11 | $1,898 | $173 |
| Tirosint | 11 | $1,412 | $128 |
| Hydrocortisone | 13 | $127 | $10 |
2021: 2 drugs
| Victoza 3-Pak | 12 | $12,883 | $1,074 |
| Tirosint | 11 | $1,387 | $126 |
2020: 3 drugs
| Victoza 3-Pak | 14 | $13,976 | $998 |
| Carbidopa-Levodopa | 11 | $452 | $41 |
| Levoxyl | 11 | $315 | $29 |
2019: 3 drugs
| Victoza 3-Pak | 12 | $11,196 | $933 |
| Prednisone | 11 | $160 | $15 |
| Metformin | 12 | $43 | $4 |
2018: 5 drugs
| Xyrem | 12 | $163,121 | $13,593 |
| Victoza 3-Pak | 12 | $10,227 | $852 |
| Tirosint | 13 | $2,341 | $180 |
| Estradiol | 14 | $1,301 | $93 |
| Metformin | 24 | $82 | $3 |
2017: 8 drugs
| Victoza 3-Pak | 11 | $8,618 | $783 |
| Tirosint | 19 | $2,474 | $130 |
| Levoxyl | 30 | $577 | $19 |
| Levothyroxine | 17 | $274 | $16 |
| Metformin | 33 | $148 | $4 |
| Spironolactone | 11 | $143 | $13 |
| Prednisone | 12 | $119 | $10 |
| Glipizide | 11 | $94 | $9 |
2016: 9 drugs
| Victoza 3-Pak | 22 | $18,551 | $843 |
| Tirosint | 23 | $3,250 | $141 |
| Vivelle-Dot | 15 | $2,351 | $157 |
| Levoxyl | 39 | $713 | $18 |
| Liothyronine | 12 | $631 | $53 |
| Valacyclovir | 11 | $525 | $48 |
| Levothyroxine | 19 | $316 | $17 |
| Metformin | 47 | $316 | $7 |
| Atorvastatin | 13 | $91 | $7 |
2015: 7 drugs
| Vivelle-Dot | 17 | $2,529 | $149 |
| Tirosint | 11 | $1,021 | $93 |
| Levoxyl | 42 | $919 | $22 |
| Valacyclovir | 13 | $390 | $30 |
| Levothyroxine | 14 | $315 | $23 |
| Losartan | 14 | $90 | $6 |
| Metformin | 12 | $50 | $4 |
2014: 7 drugs
| Vivelle-Dot | 20 | $4,187 | $209 |
| Tirosint | 13 | $1,041 | $80 |
| Levothyroxine | 34 | $471 | $14 |
| Atorvastatin | 12 | $185 | $15 |
| Losartan | 18 | $128 | $7 |
| Metformin | 13 | $97 | $7 |
| Glipizide | 13 | $50 | $4 |
2013: 3 drugs
| Vivelle-Dot | 17 | $2,734 | $161 |
| Tirosint | 12 | $786 | $66 |
| Levothyroxine | 12 | $88 | $7 |
Professional record
- NPI
- 1801138276
- Licence
- CA G24699California G24699: Current · expires 2028-07-31
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X)
- Mailing address
- 15215 National Ave, Suite 103, Los Gatos, CA, 95032
- NPI first listed
- 2013-03-22
- NPI last updated
- 2013-03-22
This is when the NPI record was last certified, not a medical board exam.